Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Statement

8 Nov 2021 07:00

RNS Number : 5723R
Kingspan Group PLC
08 November 2021
 

Kingspan Group Plc

Trading Update

 

8 November 2021

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues a Trading Update for the period to 30 September 2021.

Sales in the nine month period to 30 September were €4.72bn, up 44% on the same period in the prior year, with sales growth of 50% in the third quarter. Underlying sales (pre currency and acquisitions) were up 34% in the year to date and by 33% in the third quarter.

 

Insulated Panels sales increased by 47% in the first nine months and by 53% in the third quarter. Underlying sales were up 42% year to date and up 43% in the third quarter. The sales performance across each of the Group's key markets has evidently been strong both year to date and in the quarter. Raw material inflation has been extraordinary, with the associated recovery and the top line boosted further by buoyant volume growth overall year to date. Notably, however, order intake in the months of August and September was lower than in the same two month period last year and this trend has continued in the weeks since. The TeraSteel acquisition completed earlier in the year is performing strongly. Overall, the global Insulated Panels backlog was up 49% in volume as at 30 September versus the same point last year.

 

Insulation Boards sales in the first nine months were up 51% and up 78% in the third quarter. Underlying sales were up 32% in the year to date and by 25% in the third quarter. Sales volumes overall were in line with the third quarter of 2020 with the top line reflecting mainly the higher cost of raw materials year on year. Sales in Central and Eastern Europe, the Nordics and North America were particular highlights in the third quarter although all key markets performed well. Recent investments, such as our Kooltherm® line in Sweden have been key in driving structural adoption to high performance insulation with further developments to come globally in 2022 and 2023. The Logstor acquisition, which completed in June, is integrating fully to plan.

 

Light & Air sales in the first nine months were up 28% in the year to date and by 12% in the third quarter. Underlying sales were up 1% year to date and were level in the third quarter. Market activity both in Europe and North America has been more subdued than in other categories. The division has prioritised the integration of acquisitions made in the current and prior year and achieving category scale. 2021 is shaping up to be a further year of progress in that context.

 

Data & Flooring sales in the first nine months were up 22% and up 21% in the third quarter. Underlying sales were up by 23% in the first nine months and were up 20% in the third quarter. Datacentre demand globally is robust, offsetting a weaker office market.

 

Water & Energy sales in the first nine months increased by 32% and up 24% in the third quarter. Underlying sales were up 18% year to date and by 8% in the third quarter. The waste water and rainwater harvesting categories continue to perform well.

 

Net debt at the end of September 2021 was €636m with a cumulative acquisition spend year to date of €485m and organic capital investment of €119m.

 

Looking ahead our backlog is strong although is reducing week on week as sales activity outpaces new order placement. Underlying panels order intake volume is down 10% in the third quarter versus the same period in 2020. 2021 so far has been unusual and characterised by order placement earlier in the year than is typical as customers sought to get ahead of ongoing inflation and availability pressures. It is likely what we are experiencing now is a fallow period in order placement following that. Raw material prices have been somewhat stable in more recent weeks, albeit at record high levels and following a period of unparalleled increases. There are no signs yet of any meaningful raw materials deflation although should that come the impact would be negative. We are acutely conscious of that.

 

The activity pipeline is generally encouraging particularly in large scale logistics, data, technology and the EV automotive sectors. These applications demand high energy efficient solutions, not just on day one but over the lifetime of the building, with Kingspan technology well placed in that environment. 2021 has still to play out fully with the seasonally important fourth quarter remaining and, accordingly, we expect to deliver a full year trading profit in the region of €750m, significantly ahead of the €508.2m recorded in 2020.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVDLFBFFLZFBB
Date   Source Headline
31st Jan 20121:04 pmRNSDirector/PDMR Shareholding
30th Jan 20125:49 pmRNSHolding(s) in Company
30th Jan 20125:46 pmRNSHolding(s) in Company
27th Jan 20125:20 pmRNSHolding(s) in Company
9th Jan 20121:00 pmRNSBlocklisting Interim Review
3rd Jan 20121:00 pmRNSTotal Voting Rights
6th Dec 20113:13 pmRNSDirector/PDMR Shareholding
5th Dec 20115:48 pmRNSTotal Voting Rights
30th Nov 20114:53 pmRNSDirector/PDMR Shareholding - Amendment
30th Nov 20114:42 pmRNSTreasury Stock - Amendment
29th Nov 20113:58 pmRNSTreasury Stock
29th Nov 20113:56 pmRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSInterim Management Statement
14th Oct 20114:44 pmRNSTotal Voting Rights
14th Oct 20114:07 pmRNSHolding(s) in Company
14th Oct 20114:06 pmRNSHolding(s) in Company
14th Oct 20113:59 pmRNSHolding(s) in Company
14th Oct 20113:56 pmRNSHolding(s) in Company
14th Oct 20113:39 pmRNSAnnual Information Update
1st Sep 20113:53 pmRNSDirector/PDMR Shareholding
1st Sep 201110:21 amRNSDirector Declaration
25th Aug 20115:27 pmRNSTreasury Stock
25th Aug 20115:23 pmRNSDirector/PDMR Shareholding
22nd Aug 20117:00 amRNSHalf Yearly Report
11th Aug 20117:00 amRNSUSD200 Million Private Placement
1st Jul 20117:00 amRNSBlocklisting Interim Review
1st Jun 201112:24 pmRNSTotal Voting Rights
23rd May 20113:12 pmRNSHolding(s) in Company
19th May 201110:01 amRNSInvestor and analyst site visit
17th May 20112:54 pmRNSHolding(s) in Company
12th May 201112:18 pmRNSAGM Results
12th May 20117:00 amRNSInterim Management Statement
3rd May 201111:07 amRNSTotal Voting Rights
13th Apr 201112:11 pmRNSMerger Update
1st Apr 20112:02 pmRNSAcquisition
21st Mar 20113:00 pmRNSMerger Update
21st Mar 20112:50 pmRNSDirector/PDMR Shareholding
1st Mar 20114:38 pmRNSDirector/PDMR Shareholding
28th Feb 20117:00 amRNSFinal Results
1st Feb 20119:38 amRNSTotal Voting Rights
19th Jan 20112:16 pmRNSNotice of Results
19th Jan 20117:00 amRNSAcquisition
10th Jan 201111:39 amRNSBlocklisting Interim Review
5th Jan 20111:31 pmRNSTotal Voting Rights
4th Jan 20115:23 pmRNSDirectorate Change
22nd Dec 20106:17 pmRNSDirector/PDMR Shareholding
6th Dec 201012:31 pmRNSHolding(s) in Company
1st Dec 20106:20 pmRNSTotal Voting Rights
15th Nov 20107:00 amRNSInterim Management Statement
11th Nov 20103:36 pmRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.